Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CHENYSE:DGXNYSE:DVANASDAQ:LHCG On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCHEChemed$547.06+0.2%$567.63$512.12▼$623.61$7.99B0.54105,403 shs245,728 shsDGXQuest Diagnostics$179.31-0.3%$174.45$135.47▼$182.38$20.07B0.49991,388 shs1.02 million shsDVADaVita$136.66+0.6%$139.84$131.76▼$179.60$10.25B1.11824,229 shs1.71 million shsLHCGLHC Group$169.81$166.14$115.32▼$169.84$5.27B0.43576,665 shsN/AMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCHEChemed+0.19%-0.59%-4.25%-7.97%+2.75%DGXQuest Diagnostics-0.18%-0.40%+5.20%+7.40%+30.60%DVADaVita+0.74%+0.54%-3.01%-7.82%-3.90%LHCGLHC Group0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCHEChemed4.6812 of 5 stars2.53.03.34.93.52.51.3DGXQuest Diagnostics4.8713 of 5 stars2.34.04.24.72.52.52.5DVADaVita4.3594 of 5 stars2.01.00.04.52.41.74.4LHCGLHC GroupN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCHEChemed 3.00Buy$674.0023.20% UpsideDGXQuest Diagnostics 2.69Moderate Buy$185.733.58% UpsideDVADaVita 2.00Hold$164.5020.37% UpsideLHCGLHC Group 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest LHCG, DGX, DVA, and CHE Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/19/2025DVADaVitaTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$170.00 ➝ $164.005/6/2025DGXQuest DiagnosticsJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$180.00 ➝ $190.004/28/2025CHEChemedRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$667.00 ➝ $674.004/28/2025DGXQuest DiagnosticsPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$180.00 ➝ $200.004/23/2025DGXQuest DiagnosticsTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$182.00 ➝ $190.004/23/2025DGXQuest DiagnosticsEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetIn-Line ➝ In-Line$175.00 ➝ $180.004/23/2025DGXQuest DiagnosticsBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$175.00 ➝ $185.004/23/2025DGXQuest DiagnosticsRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$191.00 ➝ $194.004/9/2025DGXQuest DiagnosticsMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$178.00 ➝ $189.004/2/2025DGXQuest DiagnosticsRedburn PartnersSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$195.004/2/2025DGXQuest DiagnosticsRedburn AtlanticSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$195.00(Data available from 6/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCHEChemed$2.43B3.29$25.76 per share21.24$74.35 per share7.36DGXQuest Diagnostics$9.87B2.03$13.47 per share13.31$61.38 per share2.92DVADaVita$12.82B0.81$19.25 per share7.10$4.83 per share28.29LHCGLHC Group$2.22B2.37$7.51 per share22.60$52.17 per share3.25Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCHEChemed$302M$20.5326.6523.482.2712.40%27.58%18.96%7/23/2025 (Estimated)DGXQuest Diagnostics$871M$7.9122.6717.092.518.81%15.11%6.65%7/22/2025 (Estimated)DVADaVita$936.34M$10.0913.5410.750.946.63%176.11%4.66%8/5/2025 (Estimated)LHCGLHC Group$115.73M$2.0582.8335.2322.732.73%8.13%4.63%N/ALatest LHCG, DGX, DVA, and CHE EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/12/2025Q1 2025DVADaVita$1.75$2.00+$0.25$2.00$3.22 billion$3.22 billion4/23/2025Q1 2025CHEChemed$5.59$5.63+$0.04$4.86$641.78 million$646.94 million4/22/2025Q1 2025DGXQuest Diagnostics$2.15$2.21+$0.06$1.94$2.63 billion$2.65 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCHEChemed$2.000.37%N/A9.74%16 YearsDGXQuest Diagnostics$3.201.78%N/A40.46%14 YearsDVADaVitaN/AN/AN/AN/AN/ALHCGLHC GroupN/AN/AN/AN/AN/ALatest LHCG, DGX, DVA, and CHE DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/14/2025DGXQuest Diagnosticsquarterly$0.801.86%7/7/20257/7/20257/21/20255/20/2025CHEChemedquarterly$0.500.3%5/29/20255/29/20256/17/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCHEChemedN/A1.731.70DGXQuest Diagnostics0.841.441.31DVADaVita23.181.251.20LHCGLHC Group0.441.451.45Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCHEChemed95.85%DGXQuest Diagnostics88.06%DVADaVita90.12%LHCGLHC Group83.47%Insider OwnershipCompanyInsider OwnershipCHEChemed3.29%DGXQuest Diagnostics8.16%DVADaVita2.00%LHCGLHC Group4.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCHEChemed15,69514.63 million14.15 millionOptionableDGXQuest Diagnostics56,000111.64 million102.53 millionOptionableDVADaVita76,00075.50 million73.99 millionOptionableLHCGLHC Group30,00031.03 million29.54 millionOptionableLHCG, DGX, DVA, and CHE HeadlinesRecent News About These CompaniesOptum, LHC Group Put Pedal Down On Home-Based Care EffortsDecember 5, 2024 | homehealthcarenews.com3 Stocks Raising Dividends 4X Higher Than InflationSeptember 26, 2024 | finance.yahoo.comLHC orders removal of Nadra chairman citing ‘unauthorized appointment’September 8, 2024 | dawn.comLHC orders removal of Nadra chairman citing ‘unauthorised appointment’September 8, 2024 | dawn.comAccelerator report: LHC run 3 achieves record-breaking integrated luminositySeptember 4, 2024 | phys.orgNew Constraints on Magnetic Monopoles from LHC ExperimentAugust 21, 2024 | msn.comNext-generation triggers for HL-LHC and beyondMay 3, 2024 | cerncourier.comOne of Cettire’s most prominent backers has sold out entirelyApril 23, 2024 | afr.comLHC sentences lawyer to 6 months in jail for misbehaving with judgeApril 10, 2024 | dawn.comLife Healthcare Group Holdings Ltd.February 17, 2024 | wsj.comJustice Anwaarul Haq takes oath as Chief Justice LHCJuly 31, 2023 | radio.gov.pkUnitedHealth offers over $3 bln for home health firm AmedisysJune 5, 2023 | reuters.comJustice Muhammad Ameer Bhatti takes oath as new Chief Justice of LHCMay 27, 2023 | radio.gov.pkLHC stops former Punjab CM Buzdar’s arrest till ThursdayMay 5, 2023 | tribune.com.pkWhat will the Large Hadron Collider discover next?April 27, 2023 | bbc.co.ukLHC Group Stock Hits New 52-Week Low (LHCG)April 17, 2023 | thestreet.comAfter Closing On LHC Group Deal, Optum Looks To Capitalize On Home-Based Care CapabilitiesApril 15, 2023 | homehealthcarenews.comConstruction framework provider LHC Procurement Group reinforces foundations with two key Scottish hiresApril 10, 2023 | scotsman.comLHC Group 'more valuable' being in Lafayette in merger with UnitedHealth, co-founder saysApril 6, 2023 | theadvocate.comLHC strikes down colonial-era sedition law that stifled free speechApril 1, 2023 | pakistantoday.com.pkNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Stocks Getting Rare Double Upgrades From AnalystsBy Chris Markoch | June 6, 2025View 3 Stocks Getting Rare Double Upgrades From AnalystsWhy Quantum Computing Inc. Is the Quiet Winner in Quantum StocksBy Jeffrey Neal Johnson | June 18, 2025View Why Quantum Computing Inc. Is the Quiet Winner in Quantum StocksArcher's Midnight Air Taxi Soars, But Stock Doesn’t BudgeBy Jeffrey Neal Johnson | June 4, 2025View Archer's Midnight Air Taxi Soars, But Stock Doesn’t BudgeAMD Accelerates Stack Development: Share Price to FollowBy Thomas Hughes | June 16, 2025View AMD Accelerates Stack Development: Share Price to Follow3 Growth Stocks Too Small for Institutions to BuyBy Gabriel Osorio-Mazilli | June 19, 2025View 3 Growth Stocks Too Small for Institutions to BuyLHCG, DGX, DVA, and CHE Company DescriptionsChemed NYSE:CHE$547.06 +0.98 (+0.18%) Closing price 06/20/2025 03:59 PM EasternExtended Trading$548.06 +1.00 (+0.18%) As of 06/20/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.Quest Diagnostics NYSE:DGX$179.31 -0.47 (-0.26%) Closing price 06/20/2025 03:59 PM EasternExtended Trading$177.82 -1.49 (-0.83%) As of 06/20/2025 05:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.DaVita NYSE:DVA$136.66 +0.87 (+0.64%) Closing price 06/20/2025 03:59 PM EasternExtended Trading$136.78 +0.12 (+0.09%) As of 06/20/2025 06:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.LHC Group NASDAQ:LHCGLHC Group, Inc. provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations. The Home Health segment offers a wide range of services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education. The Hospice Services segment offer a wide range of services, including pain and symptom management, emotional and spiritual support, inpatient and respite care, homemaker services, and counseling. The Home & Community-Based Services segment are performed by paraprofessional personnel, and include assistance to the elderly, chronically ill, and disabled patients with activities of daily living. The Facility Based Services segment includes long-term acute care hospitals treats patients with severe medical conditions who require a high-level of care and frequent monitoring by physicians and other clinical perso More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas New All-Time Highs Coming for Broadcom? Wall Street Says Yes Smith & Wesson Stock Falls on Earnings Miss, Tariff Woes Marvell's New AI Chip Deals Capture Wall Street’s Attention Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer GE Aerospace Turns Engines Into Long-Term Profits 3 Reasons AMD Could Be the Hottest Stock of the Summer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
